RFA Superior to Steroids for Treating Knee Osteoarthritis
By HospiMedica International staff writers Posted on 16 Nov 2017 |
A new study shows that cooled radiofrequency ablation (CRFA) provides better pain reduction and functional improvement of knee osteoarthritis (OA) than intra-articular steroid (IAS) injections.
Researchers at Orthopedic Pain Specialists (Santa Monica, CA, USA), the Center for Clinical Research (Winston-Salem, NC, USA), and other institutions conducted a prospective, multicenter, randomized trial involving 151 subjects with chronic knee pain unresponsive to conservative modalities in order to compare the long-term clinical safety and effectiveness of CRFA with IAS injection in managing OA-related knee pain. Outcome measures included knee pain, Oxford Knee Score, overall treatment effect, analgesic drug use, and adverse events.
The results showed that at six months, the CRFA group had more favorable outcomes, including a 50% or greater reduction in pain score. From an initial pain score of about 7 on a 10-point scale, pain ratings at one month were about 3 in the CRFA group versus 4 in the steroid group. With further follow-up, pain scores remained lower in the CRFA group, while increasing toward the pre-treatment level in the steroid group. At six months, 74% of patients assigned to CRFA had at least a one-half reduction in pain scores, compared to 16% of those undergoing steroid injection. The study was published on November 1, 2017, in Regional Anesthesia & Pain Medicine.
“This study demonstrates that CRFA is an effective long-term therapeutic option for managing pain, and improving physical function and quality of life, for patients suffering from painful knee osteoarthritis when compared with intra-articular steroid injection,” concluded senior author Leonardo Kapural, MD, PhD, of the CCR. “The pain may return as the treated nerve regenerates; if so, repeating the CRFA procedure is a reasonable and sensible option.”
OA is a group of mechanical abnormalities involving degradation of joints, including articular cartilage and subchondral bone. Symptoms may include joint pain, tenderness, stiffness, locking, and sometimes an effusion. A variety of causes--hereditary, developmental, metabolic, and mechanical deficits--may initiate processes leading to loss of cartilage. As a result of decreased movement secondary to pain, regional muscles may atrophy, and ligaments may become more lax. OA of the knee affects about 250 million people worldwide (3.6% of the population).
Related Links:
Orthopedic Pain Specialists
Center for Clinical Research
Researchers at Orthopedic Pain Specialists (Santa Monica, CA, USA), the Center for Clinical Research (Winston-Salem, NC, USA), and other institutions conducted a prospective, multicenter, randomized trial involving 151 subjects with chronic knee pain unresponsive to conservative modalities in order to compare the long-term clinical safety and effectiveness of CRFA with IAS injection in managing OA-related knee pain. Outcome measures included knee pain, Oxford Knee Score, overall treatment effect, analgesic drug use, and adverse events.
The results showed that at six months, the CRFA group had more favorable outcomes, including a 50% or greater reduction in pain score. From an initial pain score of about 7 on a 10-point scale, pain ratings at one month were about 3 in the CRFA group versus 4 in the steroid group. With further follow-up, pain scores remained lower in the CRFA group, while increasing toward the pre-treatment level in the steroid group. At six months, 74% of patients assigned to CRFA had at least a one-half reduction in pain scores, compared to 16% of those undergoing steroid injection. The study was published on November 1, 2017, in Regional Anesthesia & Pain Medicine.
“This study demonstrates that CRFA is an effective long-term therapeutic option for managing pain, and improving physical function and quality of life, for patients suffering from painful knee osteoarthritis when compared with intra-articular steroid injection,” concluded senior author Leonardo Kapural, MD, PhD, of the CCR. “The pain may return as the treated nerve regenerates; if so, repeating the CRFA procedure is a reasonable and sensible option.”
OA is a group of mechanical abnormalities involving degradation of joints, including articular cartilage and subchondral bone. Symptoms may include joint pain, tenderness, stiffness, locking, and sometimes an effusion. A variety of causes--hereditary, developmental, metabolic, and mechanical deficits--may initiate processes leading to loss of cartilage. As a result of decreased movement secondary to pain, regional muscles may atrophy, and ligaments may become more lax. OA of the knee affects about 250 million people worldwide (3.6% of the population).
Related Links:
Orthopedic Pain Specialists
Center for Clinical Research
Latest Surgical Techniques News
- Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
- Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
- World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
- AI-Generated Synthetic Scarred Hearts Aid Atrial Fibrillation Treatment
- New Class of Bioadhesives to Connect Human Tissues to Long-Term Medical Implants
- New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation
- Minimally Invasive Valve Repair Reduces Hospitalizations in Severe Tricuspid Regurgitation Patients
- Tiny Robotic Tools Powered by Magnetic Fields to Enable Minimally Invasive Brain Surgery
- Magnetic Tweezers Make Robotic Surgery Safer and More Precise
- AI-Powered Surgical Planning Tool Improves Pre-Op Planning
- Novel Sensing System Restores Missing Sense of Touch in Minimally Invasive Surgery
- Headset-Based AR Navigation System Improves EVD Placement
- Higher Electrode Density Improves Epilepsy Surgery by Pinpointing Where Seizures Begin
- Open-Source Tool Optimizes Placement of Visual Brain Implants
- Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
- Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Channels
Critical Care
view channel
Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more
Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
Multiphoton microscopy has become an invaluable tool in neuroscience, allowing researchers to observe brain activity in real time with high-resolution imaging. A crucial aspect of many multiphoton microscopy... Read more
Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
Until now, administering cell therapies to patients on extracorporeal membrane oxygenation (ECMO)—a life-support system typically used for severe lung failure—has been nearly impossible.... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more